Evidence map›Paper›PMID 30571771›Full record

ReviewPLoS pathogens2018

Toll-like receptor 4 in acute viral infection: Too much of a good thing.

Judith Olejnik, Adam J Hume, Elke Mühlberger

Open access · goldAbstract readReview
In one paragraph

Review in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed, 1 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 1 synthesis or guideline pooled it, 204 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Nociceptor neurons shape antiviral immunity.Journal of neuroinflammation · 2026
    Review
  9. Humanized extracellular vesicles for efficient RNA delivery.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Bone and Infections: An Osteoimmunological Interplay.International journal of molecular sciences · 2026
    Review
  11. Distinct blood transcriptomic profiling underlying asthma establishment and exacerbation.The journal of allergy and clinical immunology. Global · 2026
    Article
  12. Review
  13. Review
  14. Humanized Extracellular Vesicles for Efficient RNA Delivery.bioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Judith OlejnikDepartment of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Adam J HumeDepartment of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Elke MühlbergerDepartment of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.ORCID 0000-0003-3547-9376
Boston University · US

Funding

Antiviral responses in iPSC-derived human primary cells to Ebola virus infectionR21AI126457 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MOSTOSLAVSKY, GUSTAVO, MUHLBERGER, ELKE C · 2016 to 2017
$480k
The role of TLR4 signaling in the pathogenesis of filovirus infectionR21AI135912 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MUHLBERGER, ELKE C · 2018 to 2019
$454k
NIAID NIH HHS R21 AI126457NIAID NIH HHS R21 AI135912
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HumansInflammationToll-Like Receptor 4Virus DiseasesTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID30571771
PMCPMC6301565
OpenAlexW2905159884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.